Výsledky vyhledávání - "G. M. Chertow"

Hyperparathyroidism and dialysis vintage

Autor: G M, Chertow, M, Plone, M A, Dillon, S K, Burke, E, Slatopolsky

Publikováno v: Clinical nephrology. 54(4)

Secondary hyperparathyroidism and its effects on bone and viscera are among the most important complications of end-stage renal disease. Despite its ubiquity, little is known about the treated natural history of the disorder.We assembled a cohort of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::940c5886e95d3c1e1ee756b0f9c68367
https://pubmed.ncbi.nlm.nih.gov/11076105

Zobrazit plný text záznamu

Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group

Autor: J, Lewis, M M, Salem, G M, Chertow, L S, Weisberg, F, McGrew, T C, Marbury, R L, Allgren

Publikováno v: American journal of kidney diseases : the official journal of the National Kidney Foundation. 36(4)

Atrial natriuretic peptide (ANP), an endogenous hormone synthesized by the cardiac atria, has been shown to improve renal function in multiple animal models of acute renal failure. In a recent multicenter clinical trial of 504 patients with acute tub

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e9e43f80905533726541c5b6fb5297ab
https://pubmed.ncbi.nlm.nih.gov/11157396

Zobrazit plný text záznamu

Renal nutrition in the new millennium

Autor: G M, Chertow

Publikováno v: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 10(1)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6dad1d3ff0b87b2329ab24c6ecedca92
https://pubmed.ncbi.nlm.nih.gov/10671625

Zobrazit plný text záznamu

Evidence-based organ allocation

Autor: S A, Zenios, L M, Wein, G M, Chertow

Publikováno v: The American journal of medicine. 107(1)

There are not enough cadaveric kidneys to meet the demands of transplant candidates. The equity and efficiency of alternative organ allocation strategies have not been rigorously compared.We developed a five-compartment Monte Carlo simulation model t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ad20a206eefc4d5b6f735e7cabdf95b9
https://pubmed.ncbi.nlm.nih.gov/10403353

Zobrazit plný text záznamu

A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients

Autor: G M, Chertow, M, Dillon, S K, Burke, M, Steg, A J, Bleyer, B N, Garrett, D T, Domoto, B M, Wilkes, D G, Wombolt, E, Slatopolsky

Publikováno v: Clinical nephrology. 51(1)

We have previously shown sevelamer hydrochloride (RenaGel) to be an effective and well-tolerated treatment for hyperphosphatemia in hemodialysis patients.We performed a randomized clinical trial to compare the efficacy of RenaGel alone and RenaGel wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::21ab84925f79b10d26c265f1d531f0fa
https://pubmed.ncbi.nlm.nih.gov/10939763

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání